COMMUNIQUÉS West-GlobeNewswire

Rapafusyn Pharmaceuticals to Showcase Its Molecular Glue Drug Discovery Platform at WuXi Global Forum
08/01/2025
BALTIMORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi Global Forum on [...]
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
08/01/2025
Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San Francisco Union Square NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ), a specialty biotechnology [...]
“Medical Travel Month” January 2025 Sponsored by Medical Travel & Digital Health News in SHSMD American Hospital Association’s Calendar of Health Observances
08/01/2025
OAKLAND, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Medical Travel & Digital Health News (MTDHN) , the leading bi-monthly online newsletter covering the business of medical travel and digital solutions worldwide, today [...]
MYOS Corp. Encourages Partnering with Pets for Muscle Health and Longevity
08/01/2025
CEDAR KNOLLS, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) -- MYOS Corp ., a leader in proactive muscle health supplements, encourages partnering with your pet to achieve shared longevity and muscle health goals. As cutting- [...]
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08/01/2025
Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology (“Primo”) today announced [...]
AdhereTech Announces Appointment of Dean McAlister to Board of Directors
08/01/2025
Life sciences industry veteran brings strong strategic and operational expertise SUMMIT, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) -- AdhereTech, Inc., the market-leading provider of real-time medication adherence solutions [...]
Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
08/01/2025
Last patient completed 1 year follow-up of study ALA-BCC-CT013 in December 2024. Data from follow-up will be included in FDA submission, expected in Q3 2025. Biofrontera announced highly statistically significant [...]
Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment
08/01/2025
Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMD Access the segment here ISELIN, N.J., Jan. 08, 2025 (GLOBE [...]
Capsa Healthcare Unveils the NEW Kirby Lester KL1v: The Future of Prescription Counting
08/01/2025
A Media Snippet accompanying this announcement is available by clicking on this link. COLUMBUS, Ohio, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in purposefully designed integrated solutions for [...]
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets
08/01/2025
Berry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countries MENLO PARK, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), [...]
uniQure Announces Proposed Public Offering
07/01/2025
LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
07/01/2025
VALENCIA, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07/01/2025
CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and [...]
Cassava Sciences Provides a Business Update
07/01/2025
Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer’s disease expected late first-quarter/early second-quarter 2025 Implementing cost curtailment including a workforce [...]
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
07/01/2025
HINGHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the [...]
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia
07/01/2025
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting the CNS and cardiac manifestations of Friedreich’s ataxia - - Dual route of administration enables direct delivery of AAV-based [...]
UNITY Biotechnology Reports Granting of New Employment Inducement Award
07/01/2025
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today [...]
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
07/01/2025
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07/01/2025
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]

Pages